© copyright 2014 SP, NTU. All Rights Reserved.
No.33, Linsen S. Rd., Zhongzheng Dist., Taipei City 100025,
Taiwan (R.O.C.)
TEL : (02)3366-8750~4 FAX : (02)2391-9098
Web person in charge: Tang-Yih Hsu
Contact Phone : (02)33668743
Latest Update : 2024 / 12 / 13
Privacy & Security Policy
|
|
|
|
|
|
|
 | |
| Published | : | | | | In press | : | 1. Electronic clinical surveillance system to identify unmet treatment needs for patients encountering osteoporotic fracture. Journal of Medical Internet Research. (2018.01accept) (SCI)
2. Hseuh-Ju Wang, Hsiu-Li Yang, Shu-Chiao Lin, Fe-Lin Lin Wu, Chun-Yu Wang, Li-Jiuan Shen, Chiu-Hsin Lin. Review the regulations of the compounding in developed countries and propose the guidance of the hospital pharmacy compounding in Taiwan. Formosan Journal of Medicine (2016 accept) | | | Books | : | Name：Chapter 11: Chitosan and alginate nanoparticles as oral insulin carrier. In Patenting Nanomedicine. (2012)
Authors：Wong TW, U Mandal, LJ Shen.
Name：Non-prescription Drugs (2nd edition) (2011)
Authors：Fe-Lin Lin Wu, Li-Jiuan Shen, ed.
Name：Colorimetry. IN: Encyclopedia of Medical Devices and Instrumentation (2nd edition) (2006)
Authors：Shen LJ, Mandel R and Shen WC
Name：Patient Medications Education (1999)
Authors：Li-Jiuan Shen(Writer and editor)
Name：非處方藥 (1999)
Authors：Li-Jiuan Shen(Writer and editor)
Name：家庭藥師 (1997)
Authors：沈麗娟、林瑞真、潘玫吟
Name：醫院調製藥品之管理與品項 (2017)
Authors：(作者)王雪如、林家瑜、林書巧、楊秀琍、劉玲妤、廖斐瑩；(編者)沈麗娟、林秋杏、林淑文、林慧玲、黃織芬、蘇錦玲、戴瓊芳
| | Posters & Speeches | : | Subjects：Impact and development of clinical pharmacy. (2008)
Speakers：Shen LJ
Address：Symposium for the frontier of Asia-Pacific pharmaceutical sciences.(Taichung, China Medical University)
Subjects：Correlation between therapeutic outcome of anti-tuberculosis and genetic polymorphism of NAT 2 in Taiwan aboriginals. (2008)
Speakers：Shen LJ
Address：2nd Asian Pacific International Society for the study of Xenobiotics, Shanghai, China
Subjects：如何取得與面對藥品安全資訊 (2010)
Speakers：Shen LJ
Address：臺灣內科醫學會年會 Taipei, Taiwan
Subjects：Current status of pharmacists post-graduate year training in Taiwan. (2011)
Speakers：Shen LJ
Address：Annual Meeting of the Pharmaceutical Society of Taiwan, Pingtung, Taiwan
Subjects：臨床藥學服務 (2011)
Speakers：Shen LJ
Address：海峽兩岸藥學院院長論壇, 南京
Subjects：臺灣PGY臨床藥學教育 (2012)
Speakers：Shen LJ
Address：藥物治療學暨臨床技能教學研討會, 臺北
Subjects：臺灣藥學教育制度與藥師執業內容及環境 (2012)
Speakers：Shen LJ
Address：海峽兩岸醫藥服務與管理制度交流研討會, 北京
Subjects：PST-GPP International Training Program & Travel Grant Scholarship (2012)
Speakers：Shen LJ
Address：Taipei
Subjects：臺灣六年制藥學教育對業界影響 (2013)
Speakers：Shen LJ
Address：Annual Meeting of the Taiwan Society of Health-system Pharmacists, Taipei
Subjects：從臨床觀點看藥品治療品質談起 (2014)
Speakers：Shen LJ
Address：臺灣學名藥發展策略論壇. 高雄醫學大學藥學院健康經濟與政策研究中心
Subjects：臨床試驗用藥管理的國際新趨勢 (2014)
Speakers：Shen LJ
Address：臨床研究受試者保護研討會.臺大醫院/醫策會.
Subjects：The Safe-Guard System for Patient Safety-Experiences of a Medical Center in Taiwan. (2014)
Speakers：Shen LJ
Address：Taiwan Drug Quality Forum. 台灣臨床藥學會 & 台灣諾華.
Subjects：整合式藥事服務：以Warfarin門診為例. (2014)
Speakers：Shen LJ
Address：台灣整合照護學會第一屆第二次會員代表大會暨學術研討會. 臺北主辦單位：台灣整合照護學會. 合辦單位：台北榮總高齡醫學中心
Subjects：現階段民眾面臨的用藥問題. (2014)
Speakers：Shen LJ
Address：如何建構一個安全、有效、合理的民眾用藥環境研討會.台大國際會議中心
Subjects：整合式藥事服務：以Warfarin門診為例. (2015)
Speakers：Shen LJ
Address：台灣臨床藥學會103年度中區雙月會. 彰化基教醫院
Subjects：ADR reporting experiences at NTUH (2014)
Speakers：Shen LJ
Address：藥物安全研討會. 法國大巴黎地區藥物監控中心. Hôpital Européen Georges-Pompidou (HEGP)
Subjects：缺藥問題面面觀－需求面醫院製備用藥的臨床需求與現況探討 (2015)
Speakers：Shen LJ
Address：台灣製藥發展政策與產業環境研討會. 台北. 中華民國製藥發展協會.
Subjects：Pharmacy Education at National Taiwan University & Pharmacy Practice in Taiwan. (2015)
Speakers：Shen LJ
Address：2015年中國臨床藥學會國際研討會. 南京. 中國藥科大學.
Subjects：Heparin-Binding Hemagglutinin Adhesion Peptide for Protein Drug Delivery. (2015)
Speakers：Shen LJ
Address：15th Society of Chinese Bioscientists in America (SCBA) International Symposium, Academia Sinica, Taipei
Subjects：課程設計與教學技巧 (2015)
Speakers：Shen LJ
Address：臺大醫學院104學年度醫學教育暨新進教師研習會－實用教學工作坊. 台北. 臺大醫學院.
| | Research Projects | : | Subject：Constructing Evidence-Based Clinical Decisions Supporting Research Using Population-Based Claimed Database
Duration：2014-08 ~ 2015-07
Principal Investigator：Li-Jiuan Shen
Subject：病患用藥諮詢教育計劃
Duration：2006-05 ~ 2006-12
Principal Investigator：Li-Jiuan Shen
Subject：Regulation of intracellular aginine in human cancer cells and the pharmacogenetic study of recombinant arginine deiminase
Duration：2005-08 ~ 2006-07
Principal Investigator：Li-Jiuan Shen
Subject：脫醯胺酶穿胞運輸(transcytosis) 功能之重要序列之研究
Duration：2008-08 ~ 2009-07
Principal Investigator：Li-Jiuan Shen
Subject：Effect of RNA interference of argininosuccinate synthetase and arginine deiminase on malignant cells
Duration：2008-08 ~ 2010-07
Principal Investigator：Li-Jiuan Shen
Subject：Using heparin-binding haemagglutinin adhesion (HBHA) transcytosis peptide as a novel drug delivery carrier
Duration：2007-08 ~ 2008-07
Principal Investigator：Li-Jiuan Shen
Subject：Clinical investigation of anti-tuberculosis drug isoniazid and metabolizing enzyme N-acetyltransferase 2 genetic polymorphism in Taiwan ethnic groups
Duration：2007-03 ~ 2009-02
Principal Investigator：Li-Jiuan Shen
Subject：The pharmacogenetics study of drug-metabolising enzyme genetic polymorphisms in aboriginal and Minnan/Hakka ethnic groups in Taiwan
Duration：2005-07 ~ 2006-06
Principal Investigator：Li-Jiuan Shen
Subject：Effect of recombinant arginine deiminase on nNOS-mediated NO production and neuron protection
Duration：2006-08 ~ 2007-07
Principal Investigator：Li-Jiuan Shen
Subject：Lipoamidase as a novel protein-drug delivery carrier in human intestine ( NTU Frontier Grant, Taiwan)
Duration：2006-09 ~ 2008-08
Principal Investigator：Li-Jiuan Shen
Subject：前瞻性研究計畫-醫學院-研究HBHA片段胜肽及蛋白遞送的特性
Duration：2010-09 ~ 2011-08
Principal Investigator：Li-Jiuan Shen
Subject：主動藥品安全監視系統：利用申報資料庫偵測藥品安全訊號(NSC101-3114-Y-002-003之子計畫)
Duration：2012-10 ~ 2013-09
Subject：全民健保體制下新藥創新擴散預測模型之建構.(NSC101-3114-Y-002-003之子計畫)
Duration：2012-10 ~ 2013-09
Subject：Dual modifications of recombinant arginine deiminase (rADI) for intracellular delivery and tumor targeting
Duration：2011-08 ~ 2012-07
Principal Investigator：Li-Jiuan Shen
Subject：Active pharmacovigilance system
Duration：2015-01 ~ 2017-12
Principal Investigator：Li-Jiuan Shen
|
|
|
|
|
